Ultrathin films are able to be injected using minimally-invasive syringe needles and can be used as a platform to deliver molecular and cellular drugs. The use of shape-memory polymer also enables unprecedented temperature-dependent control to allow for adhesion and removal of the nanosheets on biological surfaces.
Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine. Free-standing polymeric ultrathin films, commonly referred to as polymeric nanosheets, are one of the commonly used platforms for syringe-injectable biomedical devices because of their flexibility and conformability.
These nanosheets are less than 1 micrometer in thickness, which is thinner than a strand of hair that is usually about 100 micrometers wide. They are a promising platform for drug delivery through needle-injection. Despite recent development in nanosheets technologies using polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA), polymeric nanosheets are yet to overcome several technical challenges to serve as an effective injectable platform: namely, (1) limitation in the size of nanosheets injectable through medical needles, (2) suboptimal mechanical robustness (e.g., ripping during injection), and (3) limited control over shape recovery and motion control after injection.
To overcome these limitations, researchers from Digital Manufacturing and Design (DManD) Centre at the Singapore University of Technology and Design (SUTD) developed nanosheets using polyurethane-based shape-memory polymer (SMP) and magnetic nanoparticles (MNP) to demonstrate unprecedented capabilities to handle nanosheets. SMP offers two unique mechanical characteristics – a large change in the Young’s moduli by the change in temperature, and shape-memory effect (SME) to recover the memorised shape.
In addition, the researchers demonstrated that the fabricated SMP nanosheets can be rendered magnetic with MNP to perform non-contact motion control using an external magnetic field. Specifically, the following four capabilities were demonstrated by using the 710 nm thick nanosheet with the glass transition temperature (Tg) of 25?C: (1) syringe-injectability through the medical needles, (2) self-expandability after ejection, (3) conformability and removability on the biological surfaces, and (4) guidability in an external magnetic field. These capabilities enable in vivo practical applications as a syringe-injectable platform.
As an added advantage, the change of the modulus by temperature offers a unique capability to control the adhesion and removal of the MNP-SMP nanosheet on the biological surfaces. This would have been difficult to achieve using conventional nanosheets having a constant modulus and has not been demonstrated previously.
Envisaging the syringe-injectable delivery of molecular drugs or cellular constructs into internal organs, the researchers added the MNP-SMP nanosheets with an additional layer of PLGA, which is best known as a biomaterial used for drug delivery, to extend the functionality as a carrier of molecular and cellular drugs. This can be done without compromising the demonstrated capabilities. SMP and MNP offered the same capabilities to the nanosheets containing an additional layer of PLGA, suggesting the vast potential of the developed nanosheets for drug and cell delivery.
“The MNP-SMP nanosheets can be further functionalized by loading or printing drugs, cells and electric circuits on the surface by integrating emerging printing technologies such as inkjet printing, 3D printing and bioprinting,” said Dr Kento Yamagishi from SUTD, the lead author of the paper.
“The MNP-SMP nanosheets will contribute to the development of advanced syringe-injectable medical devices as a platform to deliver drugs and cells to the specific site or lesion in the body for minimally invasive diagnosis and therapy,” added Principal Investigator, Assistant Professor Michinao Hashimoto from SUTD.
The Latest on: Syringe-injectable medical devices
[google_news title=”” keyword=”syringe-injectable medical devices” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Syringe-injectable medical devices
- An Extensive Guide to the Best Needle-Free Lip Filler Alternativeson February 28, 2024 at 11:14 am
Or, you could go the non-invasive route, using a needle-free method to plump up your pout—the choice is yours.However, if you do decide to go the natural lip filler route, you should be armed with ...
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perioon February 28, 2024 at 12:31 am
About Milestone Scientific Inc. Milestone Scientific Inc. (MLSS) is a biomedical technology company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection ...
- Leaving the Automotive Sector Was the Best Decision This Custom Molder Ever Madeon February 27, 2024 at 2:15 pm
C & J Industries’ 25,000-square-foot expansion includes an ISO Class 7 cleanroom and room for 24 new injection molding machines.
- Medical Devices Newson February 27, 2024 at 8:46 am
Showcase your company news with guaranteed exposure both in print and online Join Louisville Business First at an awards dinner honoring health care professionals… Sold Out! Join the dinner ...
- Can Your Personal Medical Devices Be Recycled?on February 26, 2024 at 2:05 am
They also sell special containers for shipping used, discarded needles and medical waste to sites for safe disposal. But when it comes to recycling plastic devices, from asthma inhalers to insulin and ...
- Insulet posts better-than-expected quarterly resultson February 23, 2024 at 10:52 am
Medical device maker Insulet Corp posted better-than-expected quarterly profit and sales on strong demand for its wearable, tubeless insulin pumps.
- Remembering Letitia Mumford Geer, the Nurse Who Invented the One-Handed Syringeon February 19, 2024 at 4:00 pm
Many procedures and instruments developed in the late 1800s are still used by medical professionals today, including the one-handed, self-administered syringe. Syringes had already been around for ...
- GCC Syringes and Needles Market Primed to Exceed the US$ 1.33 Million Milestone by 2031on February 15, 2024 at 11:00 pm
GCC Syringes and Needles MarketIn a groundbreaking revelation, a Future Market Insights (FMI) report highlights the impressive trajectory of the GCC syringes and needles market, which soared from a ...
- JMI Syringes & Medical Devices Ltdon February 15, 2024 at 4:00 pm
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
- Yet another FDA Class 1 recall for Minnesota-made infusion syringe pumpson February 15, 2024 at 8:12 am
this week issued a Class I recall — its most serious — for the Medfusion syringe pump, the agency's third major recall of the line of devices made in Oakdale. Smiths Medical, which was based ...
via Bing News